Under normal circumstances, after the emergence of emerging technologies, the first application areas are large machines that are large enough to occupy an entire room. Only after it has matured will it be applied to relatively small subjects. Among them, the most typical performance is the development and evolution of computers in the past 70 years. Nowadays, the development of medical and health also shows this similar pattern.
At present, start-ups from various countries and regions around the world are seeking the transformation of development capabilities. You know, in the past, those capabilities were limited to key laboratories with expensive and large-scale equipment, abundant capital support, and high-end technical talents. For example, as early as the early 20th century, in order to complete the human genome sequence, Celera Genomics used nearly 300 DNA sequencers and 7000 processors, and invested up to 100 million US dollars.
At this stage, the entire human genome can be rendered and run on an ordinary desktop machine at a cost of less than $1,000. In addition to DNA sequencing, emerging start-ups in the healthcare industry also focus on treatment technologies for diseases ranging from influenza to stroke. They transfer their technology, funds, and data from a few centralized companies to the doctors and patients who need them most.
There is no doubt that these technologies can have a huge and far-reaching impact. Transferring medical tests from a few large laboratories and distributing them to households and medical centers will reduce medical costs to a greater extent, help patients improve treatment results, and realize the popularization of high-quality medical resources. Provide medical convenience for the general public. In the past, because those large-scale equipment required high capital investment and operating costs, many of them were required to be paid in installments.
However, thanks to the gradual popularity of electronic consumer devices, this industry has succeeded in reaping greater benefits from cost reductions. Just ten years ago, optics, microfluidics, and electronic devices were very expensive and rare. But now, with the help of chemical innovation and intelligent software, the cost of these tests has been reduced to a certain extent, and the quality of some tests is higher than that of large peer laboratories.
In addition to the high cost of the test itself, the costs associated with hospital diagnosis and treatment have also skyrocketed over the years. Many laboratories have received too many patient test samples, even beyond the scope of their own testing capabilities. The additional expenses caused by factors such as hospital administration and insurance can easily exceed the cost of the test itself. However, if the test is performed in a small medical center or even in the patient's own home, the costs associated with the operation of the hospital can be completely avoided, thereby greatly reducing the cost of the medical diagnosis process as a whole. In addition, testing in small medical centers and patients' homes does not require waiting in line like large laboratories, so the availability of testing is further improved, allowing more people to enjoy convenient and affordable medical care. Test service.
According to records, for patients with multiple diseases, rapid and accurate diagnosis can optimize their treatment effects to a large extent. Because only a fast and accurate diagnosis can ensure fast and accurate treatment and avoid unnecessary hospitalization and excessive antibiotic use. Therefore, with the help of advanced tools, disease diagnosis time will be shortened from a few days to a few minutes, greatly improving the efficiency of treatment.
In addition, tests performed in small medical centers and patients’ homes can also provide equipment suppliers and patients with a large amount of data, and monitor health through continuous test data. After all, traditional diagnosis can only provide a single data point. For early disease discovery, these continuous data are quite necessary to help patients receive the correct treatment as soon as possible, thereby increasing the probability of final cure, and optimizing the entire medical service process from discovery to treatment to recovery. Moreover, there are many high-quality entrepreneurial opportunities in the collection, analysis and response of relevant data.
Of course, things have two sides. These distributed medical tests also face many challenges. First of all, the promotion and certification process requires a large amount of capital investment. Secondly, the work process of the medical center may undergo major changes. Finally, as a new thing, it will inevitably be involved in the fierce market competition brought by large companies. In addition, although these tests are small in scale and low in cost, they must also strictly abide by the regulations and standards set by the Food and Drug Administration and other regulatory agencies.
Therefore, in order to truly realize the promotion and popularization of these emerging technologies, the most critical development driver is the optimization of suppliers' economies of scale. Compared with outsourcing to large centralized laboratories, the provision of diagnostic testing services in small medical centers requires suppliers to pay all costs independently. In the past, because some patients did not have equipment support for specific tests in their homes, the efficiency of remote medical diagnostic tests has been greatly reduced. However, tests that can be performed without a doctor’s prescription, such as flu, can help telemedicine service companies charge certain fees for diagnosis and physical therapy. In this case, even if the supplier is 1,000 miles away, it doesn't matter. In short, all these factors will help both suppliers and patients provide economies of scale.
In a word, at the moment, the shift in the focus of medical testing has begun, which can indeed reduce costs while improving the quality of medical care. In the future, it will become popular. Of course, continuous capital investment and resource support are still crucial. It is hoped that entrepreneurs can seize opportunities in time to benefit the whole society and enable people to live longer and healthier lives.
2.00Mm Pin Header Connector,2.0Mm Dip Vertical Type Connector,2.00Mm Pitch Vertical Type Connector,Dip Vertical Type Pin Header Connector
Shenzhen CGE Electronics Co.,Ltd , https://www.cgeconnector.com